Quick Search

PHDS HEALTHCARE RESEARCH Co., Ltd. (CRO) is a CRO company serving the world, a national high-tech enterprise, and one of the leading contract research institutions (Contract Research Organization) in the industry.

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News

So far, there are more than 1,200 client partners for registered agency services.


Release time:

2013-01-11

Beijing Boshi Zhixing Pharmaceutical Technology Co., Ltd. (PHDS) is a CRO company serving globally and has been awarded the "National Quality Credit AAA Enterprise" by the National High-tech Quality Supervision and Promotion Work Committee.

So far, there are more than 1,200 client partners for registered agency services.

Beijing Bo Shi Zhi Xing Pharmaceutical Technology Co., Ltd. (PHDS) is a global CRO company, awarded the "National Quality Credit AAA Enterprise" by the National High-tech Quality Supervision and Promotion Work Committee. It has also received the "Asia Famous Brand Award" from the (ABAS) Expert System Committee. Bo Shi Zhi Xing (PHDS) is a rapidly growing technology-based professional service company in the fields of pharmaceuticals, food, and health products, headquartered in Beijing, China, with a branch in Hong Kong, China. Its business scope covers pharmaceuticals, excipients, packaging materials, medical devices, health foods, food additives, new food resources, disinfectants, cosmetics, etc., providing product development, registration, clinical trials, human trials, market operations, and policy and regulatory consulting. It has rich industry experience, successful business, and a strong team of expert consultants in these fields. The team at Bo Shi Zhi Xing (PHDS) is experienced, with professional backgrounds in medicine, pharmacy, and related policies, and is professionally trained to undertake highly challenging tasks in this industry.

So far, PHDS has over 1,200 client partners worldwide.

Service Scope:
1. Drug Registration
2. Medical Device Registration
3. Excipients Registration
4. Packaging Materials Registration
5. Health Food Registration
6. New Food Resources Registration
7. Food Additives Registration
8. Cosmetics Registration
9. Disinfectant Products Registration
10. Water-related Products Registration
11. Imported Food Label Review

 

(China CRO PHDS)

 

Keyword:

Relevant regulations and policies


Key points and judgment principles for the quality management of non-clinical research of drugs

In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."

2024-11-22

Technical requirements for the latest declaration data electronic disc

In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.

2024-11-22

PHDS was elected as: Vice President unit of the China Food and Drug Enterprise Quality Safety Promotion Association

In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.

2024-11-22

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

2024-11-22